BindingDB logo
myBDB logout

22 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
25614116 13 Discovery of phenoxybutanoic acid derivatives as potent endothelin antagonists with antihypertensive activity.EBI Southeast University
9857090 158 Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308).EBI Bristol-Myers Squibb Pharmaceutical Research Institute
9667964 38 Selective endothelin A receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivatives.EBI Rh£Ne-Poulenc Rorer
9216842 28 Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.EBI Warner-Lambert
8410970 106 Structure-activity relationships of C-terminal endothelin hexapeptide antagonists.EBI Warner-Lambert
1315867 31 Endothelin: a new challenge.EBI Warner-Lambert
1324321 20 Design of a functional hexapeptide antagonist of endothelin.EBI Warner-Lambert
 28 Structure-activity and biophysical studies of the C-terminal hexapeptide of endothelinEBI TBA
 21 Design and synthesis of nonpeptidal endothelin receptor antagonists based on the structure of a cyclic pentapeptideEBI TBA
 32 Quantitative structure-activity relationships study of endothelin-1 analogsEBI TBA
 25 Structure-activity relationships in a series of monocyclic endothelin analoguesEBI TBA
 28 Design of C-terminal peptide antagonists of endothelin: structure-activity relationships of ET-[16–21, D-His16]EBI TBA
 5 CGS 27830, a potent nonpeptide endothelin receptor antagonistEBI TBA
11738578 26 Modifications and structure-activity relationships at the 2-position of 4-sulfonamidopyrimidine derivatives as potent endothelin antagonists.EBI Tanabe Seiyaku
11086733 56 Potent nonpeptide endothelin antagonists: synthesis and structure-activity relationships of pyrazole-5-carboxylic acids.EBI Hoechst Marion Roussel
10890162 52 Nonpeptide endothelin antagonists: from lower affinity pyrazol-5-ols to higher affinity pyrazole-5-carboxylic acids.EBI Hoechst Marion Roussel
27321813 286 From bosentan (TracleerŪ) to macitentan (OpsumitŪ): The medicinal chemistry perspective.EBI Actelion Pharmaceuticals
7731010 56 Discovery of a novel series of orally active non-peptide endothelin-A (ETA) receptor-selective antagonists.EBI Warner-Lambert
7636842 155 Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.EBI Warner-Lambert